Claims
- 1. A chemical compound selected from the group consisting of a 1H-1,2,4-triazole derivative having the formula: ##STR36## and the phytopharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof, wherein:
- R.sup.1, R.sup.2 and R.sup.3 are each independently selected from the group consisting of hydrogen, lower alkyl, lower alkyloxy, halo, nitro, cyano and trifluoromethyl;
- n is the integer 0 or 1;
- X is a member selected from the group consisting of O and S; and
- R.sup.4 is a member selected from the group consisting of alkyl, mono-, di- and trihaloalkyl, lower alkyloxy-lower alkyl, mono-, di- and trihalolower alkyloxy-lower alkyl, lower alkenyl, 2-propynyl, 3-halo-2-propynyl, cycloakyl, aryl, aryllower alkyl and aryl-lower alkenyl, wherein said aryl is selected from the group consisting of phenyl and substituted phenyl, said substituted phenyl having from 1 to 3 substituents each independently selected from the group consisting of lower alkyl, lower alkyloxy, halo, nitro, cyano, trifluoromethyl, phenyl, phenyloxy and phenylthio, provided that only one of the substituents may be selected from the group consisting of phenyl, phenyloxy and phenylthio, and wherein said phenyl and the phenyl part of said phenoxy and phenylthio are optionally substituted with up to three substituents each independently selected from the group consisting of lower alkyl, lower alkyloxy, halo, nitro, cyano and trifluoromethyl, provided that when n is 0 then R.sup.4 is other than alkyl, and wherein said alkyl, used as such or as part of another substituent, is selected from straight and branched hydrocarbon radicals having from 1 to 12 carbon atoms and said cycloalkyl is selected from cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl.
- 2. A compound selected from the group consisting of 1-[2-(2,4-dichlorophenyl)-4-(methoxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole and the phytopharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof.
- 3. A compound selected from the group consisting of 1-[2-(2,4-dichlorophenyl)-4-(ethoxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole and the phytopharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof.
- 4. A compound selected from the group consisting of 1-[2-(2,4-dichlorophenyl)-4-(propoxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole and the phytopharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof.
- 5. A compound selected from the group consisting of 1-[2-(2,4-dichlorophenyl)-4-(2-propenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole and the phytopharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof.
- 6. A compound selected from the group consisting of 1-[4-(butoxymethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole and the phytopharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof.
- 7. A compound selected from the group consisting of 1-{2-(2,4-dichlorophenyl)-4-[(2-methoxyethoxy)methyl]-1,3-dioxolan-2-ylmethyl}-1H-1,2,4-triazole and the phytopharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof.
- 8. A compound selected from the group consisting of 1-[-2-(2,4-dichlorophenyl)-4-(phenoxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole and the phytopharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof.
- 9. A compound selected from the group consisting of 1-{4-[(4-bromophenoxy)methyl]-2-(2,4-dichlorophenyl)-1,3-dioxolan-2-ylmethyl}-1H-1,2,4-triazole and the phytopharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof.
- 10. A compound selected from the group consisting of cis-1-[4-([1,1'-biphenyl]-4-yloxymethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole and the phytopharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof.
- 11. A composition for combatting a fungus comprising an inert carrier material and as an active ingredient an effective amount of a compound selected from the group consisting of a 1H-1,2,4-triazole derivative having the formula: ##STR37## and the phytopharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof, wherein;
- R.sup.1, R.sup.2 and R.sup.3 are each independently selected from the group consisting of hydrogen, lower alkyl, lower alkyloxy, halo, nitro, cyano and trifluoromethyl;
- n is the integer 0 or 1;
- X is a member selected from the group consisting of O and S; and
- R.sup.4 is a member selected from the group consisting of alkyl, mono-, di- and thrihalo-alkyl, lower alkyloxy-lower alkyl, mono-, di- and trihalo-lower alkyloxy-lower alkyl, lower alkenyl, 2-propynyl, 3-halo-2-propynyl, cycloalkyl, aryl, aryl-lower alkyl and aryllower alkenyl, wherein said aryl is selected from the group consisting of phenyl and substituted phenyl, said substituted phenyl having from 1 to 3 substituents each independently selected from the group consisting of lower alkyl, lower alkyloxy, halo, nitro, cyano, trifluoromethyl, phenyl, phenyloxy and phenylthio, provided that only one of the substituents may be selected from the group consisting of phenyl, phenyloxy and phenylthio, and wherein said phenyl and the phenyl part of said phenoxy and phenylthio are optionally substituted with up to three substituents each independently selected from the group consisting of lower alkyl, lower alkyloxy, halo, nitro, cyano and trifluoromethyl, provided that when n is 0 then R.sup.4 is other than alkyl, and wherein said alkyl, used as such or as part of another substituent, is selected from straight and branched hydrocarbon radicals having from 1 to 12 carbon atoms and said cycloalkyl is selected from cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl.
CROSS-REFERENCE TO RELATED APPLICATIONS
This is a continuation in part of our copending application Ser. No. 949,329, filed Oct. 6, 1978, now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4223036 |
Heeres et al. |
Sep 1980 |
|
4267179 |
Heeres et al. |
Mar 1981 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
949329 |
Oct 1978 |
|